Latest Stargardt disease Stories
US Orphan Designation Granted for MI-100 in June 2014, by Food and Drug Administration (FDA) DOYLESTOWN, Pa., May 4, 2015 /PRNewswire/ -- Makindus, Inc.
RnRMarketResearch.com adds “Juvenile Macular Degeneration (Stargardt Disease) – Pipeline Review, H1 2015” report to its store.
RnRMarketResearch.com adds "Blepharitis - Pipeline Review, H1 2015" to its store. This report provides an overview of the Blepharitis's therapeutic pipeline. DALLAS, Jan.
DOYLESTOWN, Pa., June 10, 2014 /PRNewswire/ -- On June 2, 2014 Makindus, Inc. a specialty pharmaceutical company, received orphan drug designation for their lead product MI-100 from the U.S.
Dr.Burton Feinerman of StemCell RegenMed announces the recruitment of patients diagnosed with Retinitis Pigmentosa, Age related Macular Degeneration and Stargardt Macular Degeneration.
Scientists have improved the eyesight of two people who were nearly blind by injecting their eyes with stem cells from human embryos.
The first ever European trials of human embryonic stem cell therapy will take place before the end of the year.
MARLBOROUGH, Mass., July 14, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc.
- A hairdresser.